
Reset all filters
01 4AbbVie Inc
02 4Adcock Ingram
03 4Clinect
04 12Gedeon Richter
05 4Recordati
06 4Sun Pharmaceutical Industries Limited
07 4Zydus Lifesciences
Reset all filters
01 4CAP
02 12CAPSULE;ORAL
03 4Capsule
04 8Hard Capsule
05 4Orodispersible Tablet
06 4Blank
Reset all filters
01 4Allowed
02 8Approved
03 4Authorized
04 8DISCN
05 4Originator
06 4RX
07 4Blank
Reset all filters
01 8CARIPRAZINE HYDROCHLORIDE
02 4React
03 16Reagila
04 1Reagila 1,5 mg capsule
05 1Reagila 3,0 mg capsule
06 1Reagila 4,5 mg capsule
07 1Reagila 6,0 mg capsule
08 4VRAYLAR
Reset all filters
01 4Australia
02 4South Africa
03 4Spain
04 8Sweden
05 4Switzerland
06 12USA
Regulatory Info : RX
Registration Country : USA
Brand Name : VRAYLAR
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 1.5MG BASE
Packaging :
Approval Date : 2015-09-17
Application Number : 204370
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : VRAYLAR
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 3MG BASE
Packaging :
Approval Date : 2015-09-17
Application Number : 204370
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : VRAYLAR
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 4.5MG BASE
Packaging :
Approval Date : 2015-09-17
Application Number : 204370
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : VRAYLAR
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 6MG BASE
Packaging :
Approval Date : 2015-09-17
Application Number : 204370
Regulatory Info : RX
Registration Country : USA
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Reagila
Dosage Form : Capsule
Dosage Strength : 1.5mg
Packaging :
Approval Date : 13/07/2017
Application Number : 20160305000045
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Reagila
Dosage Form : Orodispersible Tablet
Dosage Strength : 1.5mg
Packaging :
Approval Date : 01/08/2024
Application Number : 20230627000013
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Reagila
Dosage Form : Capsule
Dosage Strength :
Packaging :
Approval Date : 13/07/2017
Application Number : 20160305000083
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Reagila
Dosage Form : Orodispersible Tablet
Dosage Strength :
Packaging :
Approval Date : 01/08/2024
Application Number : 20230627000020
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Reagila
Dosage Form : Hard Capsule
Dosage Strength : 1.5mg
Packaging :
Approval Date : 19/06/2018
Application Number : 66364
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Reagila
Dosage Form : Hard Capsule
Dosage Strength : 3mg
Packaging :
Approval Date : 19/06/2018
Application Number : 66364
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Reagila
Dosage Form : Hard Capsule
Dosage Strength : 4.5mg
Packaging :
Approval Date : 19/06/2018
Application Number : 66364
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Reagila
Dosage Form : Hard Capsule
Dosage Strength : 6mg
Packaging :
Approval Date : 19/06/2018
Application Number : 66364
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : DISCN
Registration Country : USA
Brand Name : CARIPRAZINE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 1.5MG BASE
Packaging :
Approval Date : 2022-09-30
Application Number : 213932
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : CARIPRAZINE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 3MG BASE
Packaging :
Approval Date : 2022-09-30
Application Number : 213932
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : CARIPRAZINE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 4.5MG BASE
Packaging :
Approval Date : 2022-09-30
Application Number : 213932
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : CARIPRAZINE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 6MG BASE
Packaging :
Approval Date : 2022-09-30
Application Number : 213932
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : CARIPRAZINE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 1.5MG BASE
Packaging :
Approval Date : 2022-09-09
Application Number : 213984
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : CARIPRAZINE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 3MG BASE
Packaging :
Approval Date : 2022-09-09
Application Number : 213984
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : CARIPRAZINE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 4.5MG BASE
Packaging :
Approval Date : 2022-09-09
Application Number : 213984
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : CARIPRAZINE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 6MG BASE
Packaging :
Approval Date : 2022-09-09
Application Number : 213984
Regulatory Info : DISCN
Registration Country : USA